Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
- PMID: 11025711
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
Abstract
Purpose: The accurate prediction of pathological stage of prostate cancer using preoperative factors is a critical aspect of treatment. In 1997 Partin et al published tables predicting pathological stage using clinical stage, Gleason score and prostate specific antigen (PSA). We tested the validity of the Partin tables.
Materials and methods: From 1990 to 1996 inclusively 5,780 patients underwent bilateral pelvic lymphadenectomy and radical prostatectomy for prostate cancer at the Mayo Clinic. However, only 2,475 of these patients met all inclusion criteria of no preoperative treatment, known biopsy Gleason score, available preoperative PSA done either before biopsy or more than 28 days after biopsy and clinical stage T1, T2 or T3a. Among the 2,475 patients 15 had positive lymph nodes and planned prostatectomy was abandoned. The receiver operating characteristics (ROC) curve area, observed and predicted Partin rates of each pathological stage, and positive and negative predictive values were used to compare the Mayo study to the Partin tables.
Results: The distribution of pathological stage was organ confined in 67% of Mayo cases versus 48% in the Partin study, extracapsular without seminal vesicle or node involvement in 18% versus 40%, seminal vesicle involvement without nodes in 9% versus 7% and were positive nodes in 6% versus 5%. Using the predicted probabilities of Partin et al the ROC curve area for predicted node positive disease was 0.84 for Mayo cases compared to an estimated 0. 82 in the Partin series. The ROC curve area for predicting organ confined cancer was 0.76 for the Mayo Clinic compared to an estimated 0.73 for the Partin series. The observed rates of node positive disease were similar to those predicted (Partin) based on clinical stage, PSA and Gleason score. For organ confined disease Mayo rates were consistently higher than those predicted from the Partin series using a cut point of 0.50 or greater. Positive and negative predictive values were 0.83 and 0.49 versus 0.63 and 0.70 for the Mayo Clinic and Partin series.
Conclusions: Our study provides strong evidence that sensitivity and specificity of the Partin tables for external clinical sites are similar to what was reported.
Comment in
-
Predicting outcomes after radical prostatectomy.J Urol. 2000 Nov;164(5):1601. J Urol. 2000. PMID: 11025713 No abstract available.
Similar articles
-
Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.J Urol. 2008 Sep;180(3):904-9; discussion 909-10. doi: 10.1016/j.juro.2008.05.047. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635221
-
Validation of 2001 Partin tables in Turkey: a multicenter study.Eur Urol. 2005 Feb;47(2):185-9. doi: 10.1016/j.eururo.2004.08.002. Eur Urol. 2005. PMID: 15661412
-
The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction of prostate cancer in China.Urology. 2008 Nov;72(5):1096-101. doi: 10.1016/j.urology.2008.07.047. Epub 2008 Sep 26. Urology. 2008. PMID: 18822453 Clinical Trial.
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
-
No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.Urology. 2004 Mar;63(3):528-31. doi: 10.1016/j.urology.2003.09.064. Urology. 2004. PMID: 15028451 Review.
Cited by
-
PDE-5 Inhibitor Therapy for Erectile Dysfunction Secondary to Nerve-Sparing Radical Retropubic Prostatectomy.Rev Urol. 2005;7 Suppl 2(Suppl 2):S33-8. Rev Urol. 2005. PMID: 16985896 Free PMC article.
-
Management of patients with an increasing prostate-specific antigen after radical prostatectomy.Curr Urol Rep. 2004 Jun;5(3):179-87. doi: 10.1007/s11934-004-0035-5. Curr Urol Rep. 2004. PMID: 15161566 Review.
-
Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men.J Korean Med Sci. 2005 Apr;20(2):262-6. doi: 10.3346/jkms.2005.20.2.262. J Korean Med Sci. 2005. PMID: 15831998 Free PMC article.
-
Pre-treatment risk stratification of prostate cancer patients: A critical review.Can Urol Assoc J. 2012 Apr;6(2):121-7. doi: 10.5489/cuaj.11085. Can Urol Assoc J. 2012. PMID: 22511420 Free PMC article.
-
Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand.J Clin Pathol. 2007 Mar;60(3):290-4. doi: 10.1136/jcp.2006.037853. Epub 2006 Jun 14. J Clin Pathol. 2007. PMID: 16775117 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous